187 related articles for article (PubMed ID: 1687218)
1. Buspirone, ipsapirone and 1-(2-pyrimidinyl)-piperazine decrease cold-induced thyrotropin secretion in rats.
Broqua P; Baudrie V; Bluet-Pajot MT; Chaouloff F
Eur J Pharmacol; 1991 Nov; 204(2):141-7. PubMed ID: 1687218
[TBL] [Abstract][Full Text] [Related]
2. Are 5-HT1A autoreceptors involved in the inhibitory effect of ipsapirone on cold-elicited thyrotropin secretion?
Broqua P; Laude D; Bluet-Pajot MT; Schmidt B; Baudrie V; Chaouloff F
Neuroendocrinology; 1993 Apr; 57(4):640-7. PubMed ID: 7690117
[TBL] [Abstract][Full Text] [Related]
3. Effects of the novel anxiolytics gepirone, buspirone and ipsapirone on free feeding and on feeding induced by 8-OH-DPAT.
Gilbert F; Dourish CT
Psychopharmacology (Berl); 1987; 93(3):349-52. PubMed ID: 2893412
[TBL] [Abstract][Full Text] [Related]
4. Buspirone, 8-OH-DPAT and ipsapirone: effects on hippocampal cerebellar and sciatic fiber excitability.
Hiner BC; Mauk MD; Peroutka SJ; Kocsis JD
Brain Res; 1988 Sep; 461(1):1-9. PubMed ID: 2906267
[TBL] [Abstract][Full Text] [Related]
5. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
Meller E; Goldstein M; Bohmaker K
Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
[TBL] [Abstract][Full Text] [Related]
6. 1-(2-pyrimidinyl)-piperazine may alter the effects of the 5-HT1A agonist in the learned helplessness paradigm in rats.
Martin P
Psychopharmacology (Berl); 1991; 104(2):275-8. PubMed ID: 1678895
[TBL] [Abstract][Full Text] [Related]
7. Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration.
Gilbert F; Brazell C; Tricklebank MD; Stahl SM
Eur J Pharmacol; 1988 Mar; 147(3):431-9. PubMed ID: 2897920
[TBL] [Abstract][Full Text] [Related]
8. Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test.
Söderpalm B; Hjorth S; Engel JA
Pharmacol Biochem Behav; 1989 Jan; 32(1):259-65. PubMed ID: 2567524
[TBL] [Abstract][Full Text] [Related]
9. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
Tricklebank MD; Neill J; Kidd EJ; Fozard JR
Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
[TBL] [Abstract][Full Text] [Related]
10. The effects of alpha 2-adrenoceptor antagonists on the inhibition of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced head shakes by 5-HT1A receptor agonists in the mouse.
Dursun SM; Handley SL
Br J Pharmacol; 1993 Aug; 109(4):1046-52. PubMed ID: 8104640
[TBL] [Abstract][Full Text] [Related]
11. Relationship of increased food intake and plasma ACTH levels to 5-HT1A receptor activation in rats.
Gilbert F; Dourish CT; Brazell C; McClue S; Stahl SM
Psychoneuroendocrinology; 1988; 13(6):471-8. PubMed ID: 2907164
[TBL] [Abstract][Full Text] [Related]
12. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
Schreiber R; De Vry J
Eur J Pharmacol; 1993 Nov; 249(3):341-51. PubMed ID: 7904566
[TBL] [Abstract][Full Text] [Related]
13. Effects of buspirone and ipsapirone on schedule induced polydipsia: comparison with 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and raclopride.
Ryan CN; Evenden JL; Petterson M
Psychopharmacology (Berl); 1993; 112(1):34-44. PubMed ID: 7871008
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the alpha 2-adrenoceptor blocking properties of buspirone and ipsapirone in healthy subjects. Relationship with the plasma concentration of the common metabolite 1-(2-pyrimidinyl)-piperazine.
Berlin I; Chalon S; Payan C; Schöllnhammer G; Cesselin F; Varoquaux O; Puech AJ
Br J Clin Pharmacol; 1995 Mar; 39(3):243-9. PubMed ID: 7619663
[TBL] [Abstract][Full Text] [Related]
15. Determination of the 5-HT receptor subtype involved in 8-OH-DPAT-induced hyperlocomotion: potential difficulties arising from inadequate pharmacological tools.
Kalkman HO; Soar J
Eur J Pharmacol; 1990 Dec; 191(3):383-90. PubMed ID: 2150821
[TBL] [Abstract][Full Text] [Related]
16. [An analysis of the hypothermic action of 8-hydroxy-2-(di-N-propylamino)tetralin, 1-(2-pyrimidinyl)piperazine and its derivatives].
Komissarov IV; Dolzhenko AT; Obraztsova OG; Zin'kovskaia LIa
Biull Eksp Biol Med; 1990 Mar; 109(3):275-7. PubMed ID: 2142007
[TBL] [Abstract][Full Text] [Related]
17. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
[TBL] [Abstract][Full Text] [Related]
18. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.
Yocca FD; Iben L; Meller E
Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034
[TBL] [Abstract][Full Text] [Related]
19. 8-OH-DPAT and buspirone analogs inhibit the ketanserin-sensitive quipazine-induced head shake response in rats.
Yocca FD; Wright RN; Margraf RR; Eison AS
Pharmacol Biochem Behav; 1990 Jan; 35(1):251-4. PubMed ID: 2138331
[TBL] [Abstract][Full Text] [Related]
20. Reversal of helpless behavior in rats by putative 5-HT1A agonists.
Giral P; Martin P; Soubrié P; Simon P
Biol Psychiatry; 1988 Feb; 23(3):237-42. PubMed ID: 2892540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]